Cancer immunotherapy & LCH fan MD, PhD #gustaveroussy
Institut Gustave Roussy, Paris
Joined October 2017
- Tweets93
- Following174
- Followers151
- Likes150
Camille Bigenwald retweeted
Important mechanistic study on ICAHT from our French colleagues @GustaveRoussy highlighting that lymphodepletion alone is insufficient to explain prolonged cytopenia after CART
…a second inflammation / CAR-mediated hit within the BM is needed 👆
science.org/doi/pdf/10.1126/…
Camille Bigenwald retweeted
CAR T cells in the bone marrow maintain an activation state that results in inflammation that leads to hypoplasia @ScienceTM @CBigenwald 🇨🇵
science.org/doi/10.1126/scit…
Camille Bigenwald retweeted
Modifying a patient’s gut microbiome may enhance the efficacy of CAR T-cell therapy, according to research from @GustaveRoussy published in the AACR journal @CD_AACR. Learn more on the #AACRBlog: brnw.ch/21wTRa6 @CBigenwald
Camille Bigenwald retweeted
Now online in @CD_AACR: Gut Microbiota Modulation through Akkermansia spp. Supplementation Increases CAR-T cell Potency - by Laura Marcos-Kovandzic, @CBigenwald, Laurence Zitvogel, and colleagues doi.org/10.1158/2159-8290.CD… @GustaveRoussy
Camille Bigenwald retweeted
3km2 repris aux russes. Notre reportage en Ukraine
🇺🇦 Sur le front est, les Ukrainiens continuent de grappiller du terrain au prix de lourdes pertes, même si les Russes détiennent toujours 20% du pays. #JT20h
Camille Bigenwald retweeted
Thrilled to share our first study on aging from @MiriamMerad lab @IcahnMountSinai @TischCancer @SinaiImmunol in which we demonstrate how aging promotes cancer. We show that: (1/n)
science.org/doi/10.1126/scie…
Camille Bigenwald retweeted
1/23 We are excited to announce that our most recent study “In vivo dendritic cell reprogramming for cancer immunotherapy” was published in @ScienceMagazine.
science.org/doi/10.1126/scie…
Here is a summary of what we discovered!
Camille Bigenwald retweeted
🖼️ Yan Pei-Ming donne un visage à l’Institut avec un portrait monumental du professeur Gustave Roussy.
Exécuté et offert par Yan Pei-Ming, peintre franco-chinois de renommée internationale, le portrait en 2,80 mètres par 2,40 mètres du Pr Gustave Roussy est accroché dans le hall de l’Institut, accueillant les patients, leurs proches, les visiteurs et le personnel.
🎯 Il symbolise la mission et l’héritage du fondateur de l’Institut, père de l’oncologie moderne, dont les travaux continuent d’influencer la recherche contre le #cancer.
Yan Pei-Ming l’a réalisé à l’occasion des 90 ans de la création par le Pr Roussy de l’Institut du Cancer, et des 150 ans de la naissance de ce médecin-chercheur visionnaire.
Lire le communiqué de presse 👉 gustaveroussy.fr/fr/yan-pei-…
Camille Bigenwald retweeted
📣 Congratulations to this year's #EHAGrants winners! We look forward to seeing them advance the field of #hematology through new collaborations and resources. Do you have a research idea in need of support? The call for #EHA Grants is now open: eha.fyi/Grants2025
Very grateful to our star speakers for great science during our Cell Therapy conf @GustaveRoussy @FGinhoux @HelftJulie @j_eyquem
@BelkaidLab
@FGinhoux
@lab_rezvani
@MarsonLab
@Majzner_Lab
@HelftJulie
@alena_grosvidal
@amigorena
@RoychoudhuriLab
@LucaGattinoni
@drclaireroddie
Camille Bigenwald retweeted
Out in @CellCellPress today! We describe the first humans with inherited, complete FLT3L deficiency. Despite a lack of most dendritic cells, they reached adulthood. See the thread below for the main highlights of our paper. cell.com/cell/fulltext/S0092…
Camille Bigenwald retweeted
Proud to share the results of our study on the effect of prostaglandin E2 on T cells, which was just published in Nature in which we discovered a new role for PGE2 in inhibiting interleukin-2 (IL-2) sensing and signalling in tumor-reactive T cells nature.com/articles/s41586-0…
Camille Bigenwald retweeted
IMPROVING ADOPTIVE CELL THERAPY
Deadline for abstract submission at : April 2, 2024
Please submit your abstract to the following address:
[email protected]
Camille Bigenwald retweeted
⏳REGISTER NOW⌛️while there's still ⏲️ for the FREE International ImmunoSchool introducing everyone that's interested to experts from around the 🌍 who will be discussing challenges & opportunities for cancer immunotherapy. Sign up here >>> eventbrite.com/e/internation…
@miriammerad
Camille Bigenwald retweeted
Fantastic meeting on Cell Therapy in Paris, May 2024!
@j_eyquem @BelkaidLab @FGinhoux @lab_rezvani @MarsonLab @Majzner_Lab @HelftJulie @alena_grosvidal @amigorena @RoychoudhuriLab @LucaGattinoni @drclaireroddie @at_Mitralab @LaurieMengerLab @CecileAlanio @MichelSadelain
Save the date ! 📆
@GustaveRoussy organise une rencontre internationale sur l'amélioration de la thérapie cellulaire adoptive.
👉 Rendez-vous les 30-31/05 au @CRCordeliers.
Inscriptions : billetweb.fr/improving-adopt…
For all the cell therapy lovers, don't miss this conference in Paris! @GustaveRoussy @ @FITC_cancer
Fantastic meeting on Cell Therapy in Paris, May 2024!
@j_eyquem @BelkaidLab @FGinhoux @lab_rezvani @MarsonLab @Majzner_Lab @HelftJulie @alena_grosvidal @amigorena @RoychoudhuriLab @LucaGattinoni @drclaireroddie @at_Mitralab @LaurieMengerLab @CecileAlanio @MichelSadelain
Camille Bigenwald retweeted
Very excited to share SOPA!
This has been a wonderful collaboration with Quentin Blampey, Paul-Henry Cournède and @FGinhoux
We present a technology-invariant pipeline for analyses of image-based spatial-omics. Compatible with the latest technologies!
biorxiv.org/content/10.1101/…
Camille Bigenwald retweeted
🎅Le #PèreNoël a eu un #cancer... et en a guéri grâce aux équipes de @gustaveroussy.
👀Découvrez cette « histoire vraie. »
📽️Conçu par @PublicisConseil, réalisé par Vladimir de Fontenay et produit par @Iconoclast_tv, le film est un #ConteDeNoëlModerne ⤵️
vu.fr/ZnJkK